Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.40 -0.05 (-11.14%)
As of: Oct 23, 2026 · 3:40 PM EDT

Pasithea Therapeutics (KTTA) Revenue (2021 - 2022)

Updated

Pasithea Therapeutics (KTTA) reported Revenue of $240,712 for Q4 2022, up 10.1% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Revenue (2021 - 2022) Analysis & Trends

For FY2022, Pasithea Therapeutics posted Revenue of $486,559.

  • By year, Revenue came in at $15,062 in FY2021.
  • Per Business Quant data, the three quarters before Q4 2022 came in at $218,608 (Q3 2022), $13,581 (Q2 2022) and $13,658 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,131.95 Bn 1,100.53 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 635.80 Bn 555.66 Bn 17.30 Bn 25.40 Bn
3 AbbVie 506.62 Bn 479.73 Bn 12.70 Bn 16.99 Bn
4 Merck 358.64 Bn 313.02 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 292.18 Bn 256.17 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 265.70 Bn 239.39 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.74 Bn 193.14 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 195.25 Bn 169.45 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.25 Bn 117.90 Bn 10.94 Bn 15.03 Bn
10 Pasithea Therapeutics 12.84 Mn -142.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 240,712.00
Sep 30, 2022 218,608.00
Jun 30, 2022 13,581.00
Mar 31, 2022 13,658.00
Sep 30, 2021 -508.00
API Access

Pasithea Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=KTTA&period=max&api_key=YOUR_API_KEY